The results showed that the IC50 value significantly decreased after inhibiting the effect of methyltransferase, thereby suggesting that CARM1 indeed promoted SCLC chemoresistance by methylating Smad7. The gene discussed is CARM1; the disease is small cell lung carcinoma.